HomeCompareDITEX vs PFE

DITEX vs PFE: Dividend Comparison 2026

DITEX yields 2.66% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DITEX wins by $232.36M in total portfolio value
10 years
DITEX
DITEX
● Live price
2.66%
Share price
$12.71
Annual div
$0.34
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$232.41M
Annual income
$216,756,030.77
Full DITEX calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — DITEX vs PFE

📍 DITEX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDITEXPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DITEX + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DITEX pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DITEX
Annual income on $10K today (after 15% tax)
$226.05/yr
After 10yr DRIP, annual income (after tax)
$184,242,626.15/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, DITEX beats the other by $184,220,306.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DITEX + PFE for your $10,000?

DITEX: 50%PFE: 50%
100% PFE50/50100% DITEX
Portfolio after 10yr
$116.23M
Annual income
$108,391,144.74/yr
Blended yield
93.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

DITEX
No analyst data
Altman Z
1.9
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DITEX buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDITEXPFE
Forward yield2.66%6.13%
Annual dividend / share$0.34$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$232.41M$49.6K
Annual income after 10y$216,756,030.77$26,258.71
Total dividends collected$231.23M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DITEX vs PFE ($10,000, DRIP)

YearDITEX PortfolioDITEX Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,232$531.88$9,153$693.39+$2.1KDITEX
2$13,135$1,116.64$8,593$849.25+$4.5KDITEX
3$16,495$2,440.78$8,336$1,066.78+$8.2KDITEX
4$23,379$5,729.33$8,437$1,384.80+$14.9KDITEX
5$40,194$15,178.32$9,013$1,875.40+$31.2KDITEX
6$91,783$48,775.75$10,306$2,680.72+$81.5KDITEX
7$306,395$208,187.21$12,820$4,101.38+$293.6KDITEX
8$1,626,873$1,299,030.59$17,673$6,826.70+$1.61MDITEX
9$14,633,265$12,892,510.36$27,543$12,591.86+$14.61MDITEX
10$232,413,624$216,756,030.77$49,560$26,258.71+$232.36MDITEX

DITEX vs PFE: Complete Analysis 2026

DITEXStock

The investment seeks the maximum amount of current income exempt from federal income tax as is consistent with the preservation of capital. The fund invests at least 80% of its assets in municipal bonds rated, at the time of purchase, A or higher or the unrated equivalent as determined by the adviser. The fund may invest up to 20% of its assets in municipal bonds rated below A, including bonds rated below investment grade ("high yield" or "junk" bonds) or the unrated equivalent as determined by the adviser. The dollar-weighted average maturity of the fund&#39;s portfolio generally is between three and ten years.

Full DITEX Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this DITEX vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DITEX vs SCHDDITEX vs JEPIDITEX vs ODITEX vs KODITEX vs MAINDITEX vs JNJDITEX vs MRKDITEX vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.